When does it happen, and how fast?
Bone loss does not begin after the menopause but about a year before the last period. The figures from the SWAN study are:
- The transition (from 1 year before to 2 years after the last period) — the fastest phase: 2.46% a year at the spine and 1.76% a year at the hip.
- Total loss over those three years: an average of 10.6% at the spine and 9.1% at the femoral neck.
- Afterwards (2-5 years after the last period): the rate slows but does not stop — roughly 1% a year at both sites.
Why this matters so much. The thinning of the bone's internal structure during the transition leaves 6.3% of permanent damage. Bone density can later be raised to some extent, but this damage to the internal architecture cannot be reversed by medicines. That is why being assessed at the start of this window is worth more than intervening later.
Who is at higher risk?
Factors that cannot be changed
- Older age
- Family history of osteoporosis; a hip fracture in a parent
- Having had a fracture after only a minor knock
Factors that can be changed
- Loss of more than 3 cm in height — this can indicate a silent vertebral collapse
- Frequent falls, poor balance, loss of muscle mass
- Inactivity
- Low body weight (body mass index below 18)
- Vitamin D deficiency; a diet low in calcium and protein
- Smoking; more than 2 standard drinks of alcohol a day
Some medicines also accelerate bone loss directly — corticosteroids, certain medicines that reduce stomach acid, and some medicines used in breast cancer treatment. Tell your doctor about any medicines you take regularly.
Who should have a bone density scan?
A bone density scan (DEXA) is not a test everyone should have; risk is assessed first.
- Aged 65 and over: a scan is recommended if never done before, even without additional risk factors.
- Under 65: rather than scanning directly, the 10-year fracture probability is first calculated with a tool such as FRAX; a scan follows if risk is identified.
How often is it repeated?
- If the result is normal and hormone therapy is being maintained, there is little value in repeating within 5 years.
- If low bone mass is found, or rapid loss is expected, it is repeated every 1-3 years.
The limits of FRAX. FRAX is not validated below the age of 40 — it cannot be used in young women with early menopause. It also does not take account of falls risk, spine measurement or diabetes, and it tends to underestimate risk in younger women. In this age group, tools based on age and weight alone have been found more accurate.
Calcium, vitamin D and exercise
Calcium: the daily target after the menopause is 1000-1200 mg, and it should come primarily from food — 3-4 servings a day of milk, yoghurt or cheese. Supplements should be used selectively, only when intake from food is insufficient: routine calcium supplementation in low-risk women has been shown to increase the risk of kidney stones.
Vitamin D: the daily target is 800-1000 IU. While 20 ng/dL is generally accepted as the blood threshold, above 30 ng/dL is recommended for bone health. The amount right for you is set according to your blood level.
Exercise: at least 150 minutes of moderate activity a week, plus two resistance sessions. There is an important nuance here: in established bone loss, the main benefit of exercise is not increasing bone mass but improving muscle strength and balance so as to prevent falls and fractures. The programme must be built for the individual; a poorly planned one can increase the risk of falling.
In early menopause
Loss of ovarian function before 40, or menopause before 45, affects bone much earlier and much harder:
- In early menopause the overall fracture risk rises by about 36%, and the risk of fragility fracture by 48%.
- In women who reach the menopause at 45 or younger, the 10-year hip fracture risk has been found 1.6 times that of their peers.
- In this group, stopping hormone therapy triggers a wave of rapid loss at the femoral neck.
For that reason, guidelines make a strong recommendation that women with early menopause receive hormone therapy until the usual age of the menopause (around 50) — even without symptoms.
The place of hormone therapy in bone health
Hormone therapy is the first-line option for preventing menopause-related bone loss and significantly reduces fracture risk. The balance of benefit and risk is most favourable when it is started within 10 years of the menopause or before the age of 60. Bone loss accelerates again when treatment stops.
Where bone loss is established there are also prescription treatments; which is appropriate is decided by specialist assessment according to fracture risk. For all the screening tests see menopoz check-up.
This page is for information. The intervals above come from international guidelines; national screening programmes may differ. Please discuss your own screening and treatment plan with your doctor.
Sources
- SWAN (Study of Women's Health Across the Nation) — annual rate of loss in bone mineral density and in the bone's internal structure before and after the final period.
- British and International Menopause Society guidelines — bone-friendly lifestyle, calcium and vitamin D targets, and screening criteria.
- Guideline appraisals of fracture risk calculators — the lower age limit of FRAX at 40 and its tendency to underestimate risk in younger women.
- International guideline on premature ovarian insufficiency (POI) — bone loss and fracture risk in early menopause and the recommendation to maintain hormone therapy.
The information on this page is based on the national and international guidelines listed above. The page is reviewed whenever those guidelines are updated.
Practice and Contact Details
The information on this page is general. Please speak to your doctor about your own situation.
- DoctorOp. Dr. Murat Alpay — Specialist in Obstetrics and Gynaecology
- AddressOp. Dr. Murat Alpay Practice, Tekelioğlu Cd. No:51 B Kat:2, Filo Apt., 07160 Muratpaşa / Antalya
- Telephone0505 351 77 88
- HoursMonday – Saturday 09:00 – 18:00 · Closed on Sunday